An increased risk of death from melanoma (five‐year disease‐specific survival, DSS; HR, 1.9; 95% CI, 1.21–3.10; P = 0.046) and poor OS (HR, 2.0; 95% CI, 1.28–2.98; P = 0.01) were observed in the NF1 subtype compared to the reference group, BRAF (Fig. 4A,B). This evidence concerns the gene BRAF and melanoma.